This study characterizes the costs of recommended initial HIV antiretroviral therapy regimens in the United States from 2012 to 2018 and the magnitude of cost changes over time.
No takes yet. Share an insight, caveat, or question.
McCann et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: